clarithromycin has been researched along with Cushing Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dige-Petersen, H; Koch, C; Lanng, S; Main, KM; Müller, J; Sillesen, IB; Skov, M | 1 |
| De Schepper, J; De Schutter, I; De Wachter, E; Malfroot, A; Vanbesien, J | 1 |
2 other study(ies) available for clarithromycin and Cushing Syndrome
| Article | Year |
|---|---|
Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.
Topics: Adult; Anti-Inflammatory Agents; Aspergillosis, Allergic Bronchopulmonary; Budesonide; Clarithromycin; Cushing Syndrome; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Follow-Up Studies; Humans; Itraconazole; Risk Assessment | 2002 |
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Clarithromycin; Cushing Syndrome; Cystic Fibrosis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Infant, Newborn; Itraconazole; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous | 2003 |